DPHARMA

1.200

-0.01 (-0.8%)

Changes in Sub. S-hldr's Int (Section 138 of CA 2016)

DUOPHARMA BIOTECH BERHAD

Particulars of substantial Securities Holder

Name EMPLOYEES PROVIDENT FUND BOARD
Address TINGKAT 19, BANGUNAN KWSP, JALAN RAJA LAUT
KUALA LUMPUR
50350 Wilayah Persekutuan
Malaysia.
Company No. EPF ACT 1991
Nationality/Country of incorporation Malaysia
Descriptions (Class) Ordinary Shares

Details of changes

No Date of change
No of securities
Type of Transaction Nature of Interest
13 May 2022
28,000
Acquired Direct Interest
Name of registered holder Citigroup Nominees (Tempatan) Sdn. Bhd.
Address of registered holder Level 42, Menara Citibank, 165 Jalan Ampang, 50450 Kuala Lumpur.
Description of "Others" Type of Transaction

Circumstances by reason of which change has occurred Acquisition of 28,000 shares by Citigroup Nominees (Tempatan) Sdn. Bhd. - Employees Provident Fund Board (F.TemIslamic) IC
Nature of interest Indirect Interest
Direct (units)
Direct (%)
Indirect/deemed interest (units) 86,466,924
Indirect/deemed interest (%) 9.181
Total no of securities after change 86,466,924
Date of notice 17 May 2022
Date notice received by Listed Issuer 19 May 2022


Remarks :
Total number of Duopharma Biotech Berhad shares held are as follows:-

(a) CITIGROUP NOMINEES (TEMPATAN) SDN. BHD.
EMPLOYEES PROVIDENT FUND BOARD: 76,985,725

(b) CITIGROUP NOMINEES (TEMPATAN) SDN. BHD.
EMPLOYEES PROVIDENT FUND BOARD (AM INV): 3,200,000

(c) CITIGROUP NOMINEES (TEMPATAN) SDN. BHD.
EMPLOYEES PROVIDENT FUND BOARD (ARIM): 800,000

(d)CITIGROUP NOMINEES (TEMPATAN) SDN. BHD.
EMPLOYEES PROVIDENT FUND BOARD (TEMPLETON): 712,600

(e) CITIGROUP NOMINEES (TEMPATAN) SDN. BHD.
EMPLOYEES PROVIDENT FUND BOARD (ASIANISLAMIC) IC: 66,666

(f) CITIGROUP NOMINEES (TEMPATAN) SDN. BHD.
EMPLOYEES PROVIDENT FUND BOARD (F.TEMISLAMIC) IC: 1,136,200

(g) CITIGROUP NOMINEES (TEMPATAN) SDN. BHD.
EMPLOYEES PROVIDENT FUND BOARD (CPIAM EQ) IC: 1,849,600

(h) CITIGROUP NOMINEES (TEMPATAN) SDN. BHD.
EMPLOYEES PROVIDENT FUND BOARD (NIAM EQ) IC: 1,716,133


Announcement Info

Company Name DUOPHARMA BIOTECH BERHAD
Stock Name DPHARMA
Date Announced 19 May 2022
Category Change in the Interest of Substantial Shareholder Pursuant to Section 138 of CA 2016
Reference Number CS2-19052022-00030